Market Overview

EchoNous Reinvents Hosting System for Clinical Nursing Tools, Announcing New AI Station™ Aimed at Lowering Health System Costs

Share:

A blank sheet, a Nike designer, and advice from top health systems to
create a platform raising convenience for nurses through clinical
functionality and premium material performance

EchoNous,
an innovator focused on delivering intelligent medical tools, announces
the release of the AI
Station™
, a new docking system especially designed for emerging
nursing tools, aimed at raising convenience for nurses and lowering
costs for health systems. With the goal of reinventing what has
historically been an afterthought medical device element, EchoNous
commissioned an iconic industrial designer, Nike's former Global
Footwear Creative Director and Product Innovation Director Dave
Schenone, and listened carefully to clinicians and biomedical leaders at
one of the nation's top health systems.

This press release features multimedia. View the full release here:
https://www.businesswire.com/news/home/20180807005310/en/

EchoNous has released the AI Station™, a new docking system especially designed for emerging nursing ...

EchoNous has released the AI Station™, a new docking system especially designed for emerging nursing tools, aimed at raising convenience for nurses and lowering costs for health systems. (Photo: Business Wire)

"Everything from colors, to selection of materials, to the most minute
of daily functions were reconsidered from a blank sheet of paper and
through a fresh set of eyes," said Niko Pagoulatos, COO of EchoNous.
"Quite importantly we have integrated a ‘flexible electronic hub' into
the AI Station, aimed at both current and newly emerging AI
functionality tasks."

The AI station is a uniquely expandable platform that integrates
EchoNous' current intelligent tools, the Uscan
bladder scanner and recently released EchoNous
Vein
, as well as devices currently in development. Together, this
family of tools will powerfully utilize emerging artificial intelligence
methods along with the company's extremely miniaturized ultrasound
platform to conquer everyday problems in healthcare.

Designed from the ground up, EchoNous reimagined every component
of the nursing dock, based on first-hand direct input from nurses and
biomedical engineers in the creation of this new AI Station.

Key design elements include a more narrow lateral design for better
maneuvering in tight spaces, a lower base height to fit underneath a
hospital bed — enabling the entire cart to be closer to the patient,
probe cords docked in an "inner channel" to prevent snagging and
tripping, and importantly, the use of the best materials available today
in consideration of aggressive infection control techniques used in
hospitals today.

EchoNous chose AI Station materials with the goal of optimizing
durability and cleanability while maintaining a low weight for ease of
maneuvering. Featured materials include chemically-resistant anodized
aluminum, Tritan plastic, specifically designed for durability and
offering a much higher level of chemical resistance than previous
generation polymers, and stainless steel, which is widely recognized for
its high resistance to chemicals.

Seeking to bring a sense of art to the otherwise mundane approach to
device design, EchoNous commissioned Dave Schenone to apply his
"Attract, Engage, and Capture" framework of innovating new products.
Schenone began his distinguished design career imagining the future of
home computing at the Xerox Advanced Research Center, the Atari
Corporation, and Hewlett Packard in Silicon Valley during the 1980s. He
later held the most senior design director position at Nike for more
than two decades, overseeing the build out of the Nike Innovation
Process and leading the company's creative approach to multiple Olympic
games.

Healthcare systems interested in an in-person demonstration of EchoNous
AI Station, EchoNous Vein or Uscan should contact sales@echonous.com,
and visit www.echonous.com
for further product specifications, images and videos.

About EchoNous

Headquartered in Seattle, Washington, EchoNous, a KKR portfolio company
and parent company of Signostics, is developing an expanding family of
intelligent medical tools to help healthcare professionals solve common
everyday problems in healthcare. Beginning with the EchoNous Vein
vascular access tool and the Uscan intelligent bladder scanner, EchoNous
is applying a layer of artificial intelligence to extreme miniaturized
ultrasound to provide nurses, doctors and clinicians with high-quality,
easy-to-use tools simplifying the task at hand. CEO and industry
innovator Kevin Goodwin and EVP, COO & CIO Niko Pagoulatos, PhD, a
prolific engineering leader, together direct the company based on
decades of successful experience and new category creation in the
ultrasound industry. For more information, visit www.echonous.com.

Signostics and Uscan are Trademarks of Signostics Limited.

Caution: Federal (USA) law restricts this device to sale by or on the
order of a physician.

Tritan is a copolyester by Eastman Chemical Company

View Comments and Join the Discussion!